AVADEL PHARMACEUTICALS PLC (22) | Business Finance (10)

Browse by Subcategory

Recent Contracts

Indenture, dated as of April 4, 2022, by and between the Issuer, the Company and The Bank of New York Mellon, as Trustee (Filed With SEC on April 5, 2022)
Form of Exchange Agreement between the Issuer, the Company and certain holders of the Existing Notes (Filed With SEC on March 16, 2022)
Asset Purchase Agreement, dated as of June 30, 2020, by and between Avadel Seller, Seller Parent, Exela Buyer and Buyer Parent (Filed With SEC on July 2, 2020)
Underwriting Agreement, dated April 28, 2020, by and among the Company and Jefferies LLC, Piper Sandler & Co. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on April 29, 2020)
Registration Rights Agreement, dated February 25, 2020, by and among Avadel Pharmaceuticals plc and the Investors named therein (Filed With SEC on March 16, 2020)
Binding Term Sheet between Avadel US Holdings, Inc. and Avadel Specialty Pharmaceuticals LLC (Filed With SEC on February 14, 2019)
Form of Exchange Agreement between Avadel Finance Cayman Limited, Avadel Pharmaceuticals plc and certain holders of its February 2023 Notes (Filed With SEC on March 16, 2022)
Securities Purchase Agreement, dated February 20, 2020, by and among Avadel Pharmaceuticals plc and the Investors named therein (Filed With SEC on February 24, 2020)
Form of Registration Rights Agreement (Filed With SEC on February 24, 2020)
First Supplemental Indenture, dated as of February 6, 2019, by and among Avadel Finance Cayman Limited, Avadel Pharmaceuticals plc, and The Bank of New York Mellon (Filed With SEC on February 7, 2019)